Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris and Its Relation to Pathogenesis and Risk of the Disease
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Aswan University
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Detection of vaspin gene polymorphism
Study Overview
Brief Summary
Psoriasis is a common immune-mediated inflammatory skin disease affecting at least 100 million individuals worldwide. In Egypt, the prevalence of psoriasis ranges between 0.19% and 3% of the Egyptian people.
It is associated with poor quality of life, reduced life expectancy and multimorbidity including psoriatic arthritis, obesity and cardiovascular disease.
Vaspin (VASP, SERPIN 12) is a recently discovered adipokine that has been isolated from the visceral adipose tissue of a rat model of type 2 diabetes. It is coded by the gene SERPNA12 located on the long arm of chromosome 14q32.13 and consists of six exons and five introns.
Detailed Description
Psoriasis can present at any age. However, the disease onset appears to follow a bimodal distribution, peaking around 20-30 years of age and again around 50-60 years of age.
Psoriasis is a common skin disease characterized clinically by formation of erythematous and scaly plaques at different sites affecting mainly the extensor prominences, scalp, the lumbosacral area and the sites of trauma. It is a lifelong disease with spontaneous remissions and exacerbations.
The exact etiology is unknown, but it is considered to be an autoimmune disease mediated by T lymphocytes. It is considered the most prevalent T-cell-mediated inflammatory disease in human beings, in which, keratinocytes in focal skin regions are stimulated to proliferate with activation of the immune system mediated by primed T-lymphocytes.
There is an association of HLA antigens seen in many psoriatic patients, particularly in various racial and ethnic groups. Familial occurrence suggests its genetic predisposition .
The pathophysiology of psoriasis involves infiltration of the skin by activated T cells which stimulate the proliferation of keratinocytes. This dysregulation in keratinocyte turnover results in the formation of thick plaques. Other associated features include epidermal hyperplasia and parakeratosis. There are several treatment options available for mild psoriasis, including topical corticosteroids, vitamin D analogs, calcineurin inhibitors, keratolytics, and targeted phototherapy.
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 50 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Newly diagnosed cases or stopped treatment of at least 6 months of psoriasis patients.
- •Pateints with any age and gender.
Exclusion Criteria
- •Pregnancy and lactation.
- •Patients with chronic diseases: cardiac diseases, hepatic disorders, chronic renal failure or malignancies.
- •Patients with associated inflammatory disease such as infections and autoimmune diseases.
Arms & Interventions
Group A: Psoriasis Patients
About 30 patients suffering from Psoriasis Vulgaris will subject to vaspin gene polymorphism measure and Assessment of the disease severity will be performed by using Psoriasis area and severity index score (PASI score) for all patients.
Intervention: vaspin gene polymorphism (Biological)
Group B: Control Group
About 30 healthy participants will share as A control Group
Intervention: vaspin gene polymorphism (Biological)
Outcomes
Primary Outcomes
Detection of vaspin gene polymorphism
Time Frame: 12 Months
Assessment of vaspin gene polymorphism in psoriasis patients to determine the disease severity
Secondary Outcomes
No secondary outcomes reported
Investigators
Ola Mahmoud Elqousy
Specialist at Dermatology, Venereology and Andrology Department
Aswan University
